Fennec Pharmaceuticals Inc (FENC)
4.72
+0.08
(+1.72%)
USD |
NASDAQ |
Nov 21, 16:00
4.72
0.00 (0.00%)
After-Hours: 20:00
Fennec Pharmaceuticals Debt to Equity Ratio: -6.207 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
September 30, 2024 | -6.207 |
June 30, 2024 | -23.42 |
March 31, 2024 | 10.40 |
December 31, 2023 | -2.661 |
September 30, 2023 | -2.435 |
June 30, 2023 | -2.610 |
March 31, 2023 | -3.426 |
December 31, 2022 | -9.692 |
September 30, 2022 | 8.811 |
June 30, 2022 | 0.5842 |
March 31, 2022 | 0.3984 |
December 31, 2021 | 0.3163 |
September 30, 2021 | 0.2623 |
June 30, 2021 | 0.2238 |
March 31, 2021 | 0.00 |
December 31, 2020 | 0.00 |
September 30, 2020 | 0.00 |
June 30, 2020 | 0.00 |
March 31, 2020 | 0.00 |
December 31, 2019 | 0.00 |
September 30, 2019 | 0.00 |
June 30, 2019 | 0.00 |
March 31, 2019 | 0.00 |
December 31, 2018 | 0.00 |
September 30, 2018 | 0.00 |
Date | Value |
---|---|
June 30, 2018 | 0.00 |
March 31, 2018 | 0.00 |
December 31, 2017 | 0.00 |
September 30, 2017 | 0.00 |
June 30, 2017 | 0.00 |
March 31, 2017 | 0.00 |
December 31, 2016 | 0.00 |
September 30, 2016 | 0.00 |
June 30, 2016 | 0.00 |
March 31, 2016 | 0.00 |
December 31, 2015 | 0.00 |
September 30, 2015 | 0.00 |
June 30, 2015 | 0.00 |
March 31, 2015 | 0.00 |
December 31, 2014 | 0.00 |
September 30, 2014 | 0.00 |
June 30, 2014 | 0.00 |
March 31, 2014 | 0.00 |
December 31, 2013 | 0.00 |
September 30, 2013 | 0.00 |
June 30, 2013 | 0.00 |
March 31, 2013 | 0.00 |
December 31, 2012 | 0.00 |
September 30, 2012 | 0.00 |
June 30, 2012 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-23.42
Minimum
Jun 2024
10.40
Maximum
Mar 2024
-1.472
Average
--
Median
Dec 2019
Debt to Equity Ratio Benchmarks
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 58.92M |
Total Liabilities (Quarterly) | 64.09M |
Shareholders Equity (Quarterly) | -5.171M |
Current Ratio | 7.796 |
Net Debt Paydown Yield | -0.98% |